NanoRepro AG
ISIN: DE0006577109 | Ticker: NN6 | LEI: 3912008FCA63AGIMEV74
NanoRepro AG, based in Marburg an der Lahn, specializes in the development, manufacture and national and international distribution of medical self-tests and is primarily active in health planning and prevention.
The company addresses a rapidly growing market, which is characterized by the steadily increasing health awareness of the population and will continue to gain in importance in the coming years.
NanoRepro has 24 rapid tests in its portfolio and is continuously expanding it. Among others, the company has already established 2 pregnancy tests, a test for male fertility determination, a test for gastric health as well as a range of different allergy tests and tests for preventive health care on the market.
2006
Served areaWorldwide
HeadquartersUntergasse 8, 35037 Marburg – Germany
| Report | Q1 | H1 | Q3 | FY |
|---|---|---|---|---|
| Consolidated Report | GER | |||
| Corporate Governance Report | ||||
| Company Presentation | ||||
| General Presentation | ||||
| Sustainability Report | ||||
| Remuneration Report |
| Report | Q1 | H1 | Q3 | FY |
|---|---|---|---|---|
| Consolidated Report | GER | |||
| Corporate Governance Report | ||||
| Company Presentation | ||||
| General Presentation | ||||
| Sustainability Report | ||||
| Remuneration Report |
12,900,000
IPOOct. 10, 2008
Stock exchange(s)Frankfurt Stock Exchange